Imageens is an innovative and pioneering brand in the field of AI in cardiovascular health and medical imaging. Founded in 2017, the company has quickly become a leader in the market, thanks to its cutting-edge medical image processing software based on DeepTech technologies. With a strong foundation of over 10 years of technical and clinical research conducted by renowned institutions like Sorbonne Université and Johns Hopkins, Imageens has developed the world's most clinically validated technology for analyzing arterial function by MRI.

Driven by a passion for innovation, Imageens leverages advanced AI to revolutionize treatment decisions in cardiovascular health and beyond. The company's success in this field has been recognized through numerous prestigious French innovation competitions and innovation labels. Today, Imageens continues to push the boundaries of medical software, combining its groundbreaking AI technology with other components to provide comprehensive solutions for better patient outcomes.

Headquartered in Paris, France, Imageens is constantly pushing the boundaries of AI in healthcare and working towards transforming the future of medical imaging